精准移植医学:生物标志物的应用与前景
本文讨论精准医学与生物标志物的基本概念,重点聚焦肾移植领域的进展。文章 delineates 生物标志物的不同类型,评估既往提出的生物标志物在肾移植中的当前应用与不足,并概述精准医学在移植领域的潜力。
要点
- 生物标志物是精准医学的基石,旨在整合生物标志物与传统临床信息为个体患者定制医疗。
- 文章 delineates 生物标志物类型并评估既往提出的生物标志物在肾移植中的当前应用与不足。
- 迈向移植精准医学需要移植医生接受增加的复杂性、扩展的决策算法和治疗选择。
核心结论
- 移植医学正缓慢进入精准医学时代,生物标志物是精准医学的基石。
- 迈向移植精准医学需要移植医生接受增加的复杂性、扩展的决策算法和治疗选择。
研究设计与样本
- 本文为综述,讨论精准医学与生物标志物的基本概念,并聚焦肾移植领域的进展。
主要发现
- 文章 delineates 生物标志物的不同类型,并评估既往提出的生物标志物在肾移植中的当前应用与不足。
局限性
- 文章评估了既往提出的生物标志物在肾移植中的不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The concept that individuals with the same disease and a similar clinical presentation may have very different outcomes and need very different therapies is not novel. With the development of many innovative tools derived from the omics technologies, transplant medicine is slowly entering the era of precision medicine. Biomarkers are the cornerstone of precision medicine, which aims to integrate biomarkers with traditional clinical information and tailor medical care to achieve the best outcome for an individual patient. Here, we discuss the basic concepts of precision medicine and biomarkers, with a specific focus on progress in renal transplantation. We delineate the different types of biomarkers and provide a general assessment of the current applications and shortcomings of previously proposed biomarkers. We also outline the potential of precision medicine in transplantation. Moving toward precision medicine in the field of transplantation will require transplant physicians to embrace the increased complexity and expanded decision algorithms and therapeutic options that are associated with improved disease nosology.
引用
- Naesens M, Anglicheau D. Precision Transplant Medicine: Biomarkers to the Rescue. J Am Soc Nephrol. 2017. PMID: 28993504. doi:10.1681/ASN.2017010004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。